Provided by Tiger Fintech (Singapore) Pte. Ltd.

Kalvista Pharmaceuticals Inc

15.39
-0.6200-3.87%
Post-market: 15.400.0100+0.06%17:57 EDT
Volume:1.28M
Turnover:20.13M
Market Cap:765.84M
PE:-4.17
High:16.23
Open:15.90
Low:15.30
Close:16.01
Loading ...
Feb 10, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Feb 04, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 31, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 30, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Dec 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Dec 09, 2021

Major Issues Report

8-K - Current report
Oct 25, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 04, 2021

Major Issues Report

8-K - Current report
Sep 17, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 15, 2021

Major Issues Report

8-K - Current report
Sep 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 09, 2021

Major Issues Report

8-K - Current report
Jul 13, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jul 13, 2021

Major Issues Report

8-K - Current report
Jul 13, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 30, 2021

Major Issues Report

8-K - Current report
Jun 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jun 07, 2021

Major Issues Report

8-K - Current report
May 27, 2021

Correspondence

CORRESP [Cover] - Correspondence